2-(Chloromethyl) -4-Methylquinazoline CAS 109113-72-6

Description:

Chemical Name: 2-(Chloromethyl) -4-Methylquinazoline

CAS: 109113-72-6

Puritas: ≥99.0% (HPLC)

Aspectus: Palea Yellow ut pallide Brown pulveris

Intermedia pro Linagliptin (CAS: 668270-12-0) pro adultorum specie diabete mellito tractandis.

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple Linagliptin et intermedia:
Linagliptin CAS 668270-12-0
Linagliptin Parent Nucleus Intermedia CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl) -3-methylxanthine CAS 666816-98-4
2-(Chloromethyl) -4-Methylquinazoline CAS 109113-72-6
(R) -3-(Boc-Amino) piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0

Chemical Properties:

Nomen chemicum	2-(Chloromethyl) -4-Methylquinazoline
Synonyma	Linagliptin medium A
CAS Number	109113-72-6
CATTUS Number	RF-PI498
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C10H9ClN2
M. Pondus	192.64
Density	1.251
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Pallida ad Palestrina Brown Pulvis
Lepidium sativum	Sample IR spectrum congruit cum spectro vexillum
Lepidium sativum B *	Retentione temporis principii apicem exempli vexillum respondere debet
Solubilitas	Methylene Chloride solutum;Insolubilis in aqua
Puritas / Analysis Methodus	≥99.0% (HPLC)
Liquescens punctum	60.0 ad 65.0℃
Aquae (KF)	≤0.50%
Residere in Ignition	≤0.50%
Substantiae cognatae
una immunditia	≤0.30%
Totalis immunditias	≤1.0%
Test Standard	Enterprise Standard
Consuetudinem	Intermedia pro Linagliptin (CAS: 668270-12-0)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.

commoda:

FAQ:

Applicatio:

2-(Chloromethyl) -4-Methylquinazoline (CAS: 109113-72-6) adhibetur ut medium ad conficiendum Linagliptin (CAS: 668270-12-0), eiusque immunditiam.Linagliptin, sub nomine Tradjenta notae apud alios venditum, est medicamentum quod genus diabete melliti tractabat 2. Vulgo minus praefertur quam metformin et sulfonylureas sicut curatio initialis.Utitur una cum exercitatione et victu.Non commendatur in diabete specie 1 .Productionem insulin augendo et productionem glucagonis a pancreate decrescendo operatur.Linagliptin probatum est usui medicorum in Civitatibus Foederatis Americae anni 2011. Linagliptin valde potens, selectivum dipeptidylum peptidase-4 (DPP-4) inhibitor cum IC50 1 nm.